Trinity Bio ADR (TRIB) Stock Price, Quote & News

Company Profile

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Asia, Africa, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detects infectious diseases; sexually transmitted diseases, such as syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mump...

Industry: Medical Devices

Sector: Healthcare

Phone: 353 1 276 9800

Fax: 353 1 276 9888

Website: www.trinitybiotech.com

Address:

IDA Business Park, Bray, Ireland

topstockalerts Jul. 28 at 9:35 PM

Top Gainers PT2 $BIYA $CNET $TRIB $NEXR $OPK

0 · Reply

WolfinBlack Jul. 28 at 9:08 PM

Break out starting on ticker ARTW 🚨 Bullish earning news, and the float is just 2M, if this gets volume, can go up fast! If you are looking for the next big runner, make sure to position yourself in ARTW. $EZRA $EGG $TRIB $PSQH //.122

0 · Reply

ScanStock Jul. 28 at 8:51 PM

APUS wow! It is squeezing up now. Once $POLA $TRIB $BIYA $NVDA buyers move over to APUS it might create a huge FOMO rally. I really hope the shorts on APUS get squeezed out hard and burned. 🚀

0 · Reply

topstockalerts Jul. 28 at 7:40 PM

The todays Top Gainers PT2 $INLF $NEXR $OPK $TRIB $CNET

0 · Reply

MadisonRamsey Jul. 28 at 7:23 PM

$BHV $KZIA $TRIB $CCG $AFJK looking

0 · Reply

smithwaldJR Jul. 28 at 7:23 PM

APUS is squeezing up now. Once $POLA $TRIB $BIYA $NVDA buyers move over to APUS it might create a huge FOMO rally. I really hope the shorts on APUS get squeezed out hard and burned. 🚀

0 · Reply

topstockalerts Jul. 28 at 6:29 PM

Top Gainers PT2 $STFS $OPK $INLF $TRIB $PMN

1 · Reply

Stock_Catcher Jul. 28 at 6:06 PM

$TRIB $LHSW $PSQH New high of day

0 · Reply

Mikeqb20 Jul. 28 at 5:52 PM

$TRIB BEEN A WINNER A FEW TIMES!! NEXT ONE TO GO IS $OXBR #BUY.NOW

0 · Reply

topstockalerts Jul. 28 at 5:24 PM

$TRIB there it goes!!

0 · Reply

Trinity Biotech trading halted, news pending

2026-07-22T11:40:27.000Z - 6 days ago

Trinity Biotech announces strategic collaboration agreement with Latch Medical

2026-07-22T11:35:25.000Z - 6 days ago

Trinity Biotech announces plan to implement ADS ratio change

Jul 22, 2026, 7:30 AM EDT - 6 days ago

Trinity Biotech Partners with Latch Medical to Advance Biosensor-Guided Precision Drug Delivery Solutions Using CGM+ Technology

Jul 22, 2026, 7:15 AM EDT - 6 days ago

Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change

Jul 2, 2026, 8:30 AM EDT - 26 days ago

New Trinity Biotech Clinical Trial Data Shows Its CGM+ Technology Tackles a Major CGM User Problem by Going Beyond Glucose-Only Monitoring

Jun 30, 2026, 9:00 AM EDT - 4 weeks ago

Trinity Biotech's Trinovium Secures Open Compute Project Membership, Advancing Hyperscale Market Access and Commercial Validation for AI Data Center Liquid Cooling

2026-06-29T19:20:10.000Z - 4 weeks ago

Trinity Biotech terminates standby equity purchase agreement with Yorkville

Jun 29, 2026, 3:15 PM EDT - 4 weeks ago

Trinity Biotech Terminates Standby Equity Purchase Agreement with Yorkville

Jun 23, 2026, 7:30 AM EDT - 5 weeks ago

Trinity Biotech Launches Trinovium to Bring Healthcare-Grade Fluid Technology to the Rapidly Growing Multi-Billion Dollar AI Data Center Liquid Cooling Market

Jun 18, 2026, 4:00 PM EDT - 5 weeks ago

Trinity Biotech Earnings release: Q1 2026

Jun 18, 2026, 4:00 PM EDT - 5 weeks ago

Trinity Biotech Slides: Q1 2026

2026-06-16T13:30:59.000Z - 6 weeks ago

Trinity Biotech receives purchase orders for 2M units of TrinScreen HIV

Jun 16, 2026, 9:10 AM EDT - 6 weeks ago

Trinity Biotech Awarded Significant Orders for Over 2 Million TrinScreen HIV Tests And Reports Q1 2026 Financial Results

Jun 3, 2026, 8:00 AM EDT - 7 weeks ago

Trinity Biotech Registration statement: Registration filing

2026-05-13T20:46:47.000Z - 2 months ago

Trinity Biotech files to sell 167.95M American depositary shares

May 13, 2026, 8:00 AM EDT - 2 months ago

Trinity Biotech Registration statement: Registration filing

May 13, 2026, 8:00 AM EDT - 2 months ago

Trinity Biotech Registration statement: Registration filing

May 1, 2026, 9:27 AM EDT - 3 months ago

Trinity Biotech Appoints Jerry Lydon to Lead North America Commercial Operations

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Trinity Biotech Annual report: Q4 2025

Apr 30, 2026, 7:00 AM EDT - 3 months ago

Trinity Biotech Slides: Q4 2025

Mar 23, 2026, 9:23 AM EDT - 4 months ago

Trinity Biotech Announces Successful Clinical Results for Its Enhanced EpiCapture™ Prostate Cancer Test

2026-03-18T12:36:02.000Z - 4 months ago

Trinity Biotech announes collaboration agreement with University at Buffalo

Mar 18, 2026, 8:30 AM EDT - 4 months ago

Trinity Biotech Announces Collaboration with University at Buffalo to Commercialize Novel Biomarkers for Sjögren's Syndrome

2026-03-12T13:09:29.000Z - 4 months ago

Trinity Biotech begins rollout of glucose monitoring system in Brazil

Mar 12, 2026, 9:00 AM EDT - 4 months ago

Trinity Biotech Begins Rollout of Innovative Glucose Monitoring System In Key Market Following Regulatory Approval of Next-Generation Premier Hb9210 HbA1c Column System

Mar 11, 2026, 9:00 AM EDT - 4 months ago

Trinity Biotech Senior Executives to Attend ATTD 2026 to Advance Collaborations Following Strong Progress in CGM Program

2026-03-10T12:01:30.000Z - 5 months ago

Trinity Biotech announces advancements in CGM system development

2026-03-10T11:56:35.000Z - 5 months ago

Trinity Biotech says continuing to focus on Comprehensive Transformation Plan

Mar 10, 2026, 7:55 AM EDT - 5 months ago

Trinity Biotech Announces Further Major Technical Breakthroughs in Advancing Next Generation CGM+ Platform

2026-03-10T11:50:13.000Z - 5 months ago

Trinity Biotech sees Q4 revenue $11.5M-$12.5M vs. $15.9M last year

Mar 10, 2026, 7:45 AM EDT - 5 months ago

Trinity Biotech Provides Business and Trading Update

2026-02-25T14:17:27.000Z - 5 months ago

Trinity Biotech files to sell 35.28M American Depositary Shares for holders

2026-02-25T14:14:32.000Z - 5 months ago

Trinity Biotech secures $25M standby equity purchase agreement

Feb 25, 2026, 9:00 AM EST - 5 months ago

Trinity Biotech Secures $25 Million Financing Commitment to Support Growth Initiatives

Feb 25, 2026, 7:00 AM EST - 5 months ago

Trinity Biotech Registration statement: Registration filing

2026-02-20T22:10:49.000Z - 5 months ago

Trinity Biotech receives noncompliance notification from Nasdaq

Feb 20, 2026, 5:00 PM EST - 5 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

2026-02-13T22:10:18.000Z - 5 months ago

Trinity Biotech receives noncompliance notification from Nasdaq

Feb 13, 2026, 5:00 PM EST - 5 months ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Nasdaq Minimum Bid Price Requirement

2026-02-10T18:35:27.000Z - 6 months ago

Trinity secures regulatory approval for upstream manufacturing activities

Feb 10, 2026, 1:28 PM EST - 6 months ago

Trinity Biotech Secures Regulatory Approval for Commencement of Upstream Manufacturing Activities of Uni-Gold™ HIV Rapid Test Under Its Offshored and Outsourced Model, Supporting Financial Performance Transformation

2026-02-10T13:27:39.000Z - 6 months ago

Trinity achieves IFCC Gold Classification for Premier Hb9210 HbA1c Analyser

Feb 10, 2026, 8:00 AM EST - 6 months ago

Trinity Biotech Glucose Monitoring Innovation Achieves Unique Global Recognition: Diabetes Care Premier Hb9210™ HbA1c Analyser Becomes the Only System Awarded Prestigious IFCC Gold Classification for 2026

2026-01-15T21:35:23.000Z - 6 months ago

Trinity Biotech files to sell 55.89M American depositary shares

Dec 23, 2025, 9:30 AM EST - 7 months ago

Trinity Biotech Slides: Q3 2025

2025-12-23T13:55:09.000Z - 7 months ago

Trinity Biotech enters series of agreements with Perceptive Advisors funds

Dec 23, 2025, 8:50 AM EST - 7 months ago

Trinity Biotech Announces Agreements to Strengthen Capital Structure and Support Growth Initiatives

Dec 23, 2025, 8:30 AM EST - 7 months ago

Trinity Biotech Slides: Q2 2025

Dec 23, 2025, 7:32 AM EST - 7 months ago

Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests

Dec 15, 2025, 9:15 AM EST - 8 months ago

Trinity Biotech Expands Global Rollout of High-Capacity Column System for FDA-Cleared HbA1c Testing Solution After Securing Regulatory Clearances

Nov 18, 2025, 9:00 AM EST - 9 months ago

Trinity Biotech Secures Major Regulatory Approval for Offshored and Outsourced Manufacturing of Its Market Leading Uni-Gold Rapid HIV Test, Further Accelerating Financial Performance Transformation

Nov 14, 2025, 9:00 AM EST - 9 months ago

Trinity Biotech Announces Collaboration to Advance Epigenetic Analysis for EpiCapture Prostate Cancer Test

Oct 27, 2025, 9:00 AM EDT - 9 months ago

Trinity Biotech Welcomes Perceptive Advisor's Indication of Potential Debt-to-Equity Conversion - Strengthening Balance Sheet and Supporting Growth

Sep 2, 2025, 9:30 AM EDT - 11 months ago

Trinity Biotech Regains Compliance with Nasdaq Listing Requirements

Aug 21, 2025, 9:00 AM EDT - 1 year ago

Trinity Biotech Appoints Paul Tivnan as Non-Executive Director

Aug 20, 2025, 9:00 AM EDT - 1 year ago

Regulatory Approval Granted for Commencement of Trinity Biotech's Offshored and Outsourced Manufacturing of its Flagship Rapid HIV Test, Facilitating Strategic and Financial Performance Transformation

Aug 14, 2025, 9:00 AM EDT - 1 year ago

Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service

Aug 12, 2025, 8:45 AM EDT - 1 year ago

Trinity Biotech Achieves Breakthrough Clinical Trial Results for Redesigned CGM Sensor

Aug 7, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Announces Launch of FDA-cleared Preeclampsia Testing Service

Jul 24, 2025, 8:20 AM EDT - 1 year ago

Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market

Jul 1, 2025, 9:00 AM EDT - 1 year ago

Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Trinity Biotech Slides: Q1 2025

Jun 24, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Earnings release: Q4 2024

May 16, 2025, 6:00 AM EDT - 1 year ago

Trinity Biotech Annual report: Q4 2024

May 15, 2025, 4:00 PM EDT - 1 year ago

Trinity Biotech Publishes Fourth Quarter and Fiscal Year 2024 Financial Results & Provides a Business Update

Mar 21, 2025, 8:00 AM EDT - 1 year ago

Trinity Biotech Registration statement: Registration Filing

Mar 14, 2025, 4:30 PM EDT - 1 year ago

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares and Nasdaq Minimum Bid Price Requirement

Mar 13, 2025, 7:30 AM EDT - 1 year ago

Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process

Feb 28, 2025, 8:30 AM EST - 1 year ago

Trinity Biotech Announces Additional Funding To Support Transformation Plan & Continued Development of the Company's Continuous Glucose Monitoring Technology

Feb 6, 2025, 7:30 AM EST - 1 year ago

Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial

Jan 28, 2025, 7:20 AM EST - 1 year ago

Trinity Biotech Announces Breakthrough Results From Pre-Pivotal Trial of Disruptive Continuous Glucose Monitoring (CGM) Technology

Dec 24, 2024, 8:33 AM EST - 1 year ago

Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan

Dec 18, 2024, 11:00 AM EST - 1 year ago

Trinity Biotech Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV

Nov 29, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings Call Transcript: Q3 2024

Nov 15, 2024, 10:00 AM EST - 1 year ago

Trinity Biotech Earnings release: Q3 2024

Nov 15, 2024, 9:00 AM EST - 1 year ago

Trinity Biotech Announces Q3 2024 Financial Results

Nov 15, 2024, 7:00 AM EST - 1 year ago

Trinity Biotech Registration statement: Registration Filing

Nov 14, 2024, 8:07 AM EST - 1 year ago

Trinity Biotech to Announce Q3 2024 Financial Results

Oct 25, 2024, 8:45 AM EDT - 1 year ago

Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform

Oct 25, 2024, 8:45 AM EDT - 1 year ago

Trinity Biotech Enters Oncology Space with Acquisition of Prostate Cancer Focused EpiCapture

Oct 7, 2024, 8:15 AM EDT - 1 year ago

Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology

Sep 24, 2024, 4:05 PM EDT - 2 years ago

Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market

Sep 18, 2024, 4:05 PM EDT - 2 years ago

Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer

Sep 9, 2024, 4:05 PM EDT - 2 years ago

Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology

topstockalerts Jul. 28 at 9:35 PM

Top Gainers PT2 $BIYA $CNET $TRIB $NEXR $OPK

0 · Reply

WolfinBlack Jul. 28 at 9:08 PM

0 · Reply

ScanStock Jul. 28 at 8:51 PM

APUS wow! It is squeezing up now. Once $POLA $TRIB $BIYA $NVDA buyers move over to APUS it might create a huge FOMO rally. I really hope the shorts on APUS get squeezed out hard and burned. 🚀

0 · Reply

topstockalerts Jul. 28 at 7:40 PM

The todays Top Gainers PT2 $INLF $NEXR $OPK $TRIB $CNET

0 · Reply

MadisonRamsey Jul. 28 at 7:23 PM

$BHV $KZIA $TRIB $CCG $AFJK looking

0 · Reply

smithwaldJR Jul. 28 at 7:23 PM

APUS is squeezing up now. Once $POLA $TRIB $BIYA $NVDA buyers move over to APUS it might create a huge FOMO rally. I really hope the shorts on APUS get squeezed out hard and burned. 🚀

0 · Reply

topstockalerts Jul. 28 at 6:29 PM

Top Gainers PT2 $STFS $OPK $INLF $TRIB $PMN

1 · Reply

Stock_Catcher Jul. 28 at 6:06 PM

$TRIB $LHSW $PSQH New high of day

0 · Reply

Mikeqb20 Jul. 28 at 5:52 PM

$TRIB BEEN A WINNER A FEW TIMES!! NEXT ONE TO GO IS $OXBR #BUY.NOW

0 · Reply

topstockalerts Jul. 28 at 5:24 PM

$TRIB there it goes!!

0 · Reply

topstockalerts Jul. 28 at 5:09 PM

Midday Top Gainers PT2 $OPK $STFS $POLA $FIRY $TRIB

0 · Reply

stocksweets Jul. 28 at 3:57 PM

$TRIB and $PFSA is next 🔥

0 · Reply

kd1313 Jul. 28 at 3:35 PM

$TRIB $TRIB 675k shares now. STAY AWAY. This is a dilution pig. They will be issuing more shares soon as they are running out of money.

0 · Reply

Stannyman5000 Jul. 28 at 2:52 PM

$TRIB will be a runner like dfns in my opinion

0 · Reply

Think_Bigly Jul. 27 at 7:52 PM

$TRIB Huge Market Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports https://www.streetinsider.com/General+News/Nvidia+in+talks+with+OpenAI+to+guarantee+%24250+billion+financing+for+data+center%2C+WSJ+reports/26814880.html

0 · Reply

Think_Bigly Jul. 26 at 9:57 PM

$TRIB One good partner deal. $100+

0 · Reply

Think_Bigly Jul. 26 at 9:35 PM

$TRIB : Now only 675k shares.. - Sales now expanding along with margins. - Prostate & PrePsia in development - Two sigificant partner potentials: CGM+ and Data Center Cooling: $4 billion in 2026 to $27 billion by 2033. Sell www.immco.com/ 3.4M pregnant tests and 3M dry eye biomarker testing potential. Look this up. 10% market share - $50M/yr. These are unique biomarker sets.

0 · Reply

deepthinker Jul. 25 at 5:07 PM

$TRIB We have this ongoing fiction that somehow Trinity is an independent company. Well, it’s not. It’s owned by Perceptive. My guess is that Perceptive restructures the thing one way or another soon if there is no strategic partner willing to kick in $50 or $60 million for the CGM.

0 · Reply

deepthinker Jul. 25 at 1:51 PM

$TRIB As I’ve said, it’s pretty much now or never on the strategic partner. They (supposedly) have a unique device on the cusp of pivotal trials, but they can’t interest anyone important? They certainly need help from Perceptive. This is where I would hope all those connections would pay off.

0 · Reply

kd1313 Jul. 25 at 6:25 AM

$TRIB you coming back yet to pump this worthless pig? Where’s your buddy @TherealDave214

0 · Reply

TwongStocks Jul. 24 at 8:02 PM

Today's reverse split results: $DBGI 1 for 40 Previous close $0.5010, $20.04 split-adjusted Today's high $19.00 Today's close $12.90 🔴Down 35.63% $FFAI 1 for 150 Previous close $0.0717, $10.755 split-adjusted Today's high $10.84 (premarket) Today's close $6.49 🔴Down 39.66% $TRIB 1 for 30 Previous close $0.2986, $8.958 split-adjusted Today's high $9.85 Today's close $8.44506 🔴Down 5.73%

0 · Reply

Market Cap	1.01M
Revenue (ttm)	43.79M
Net Income (ttm)	-37.38M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-85.36%
Debt to Equity Ratio	-1.46

Volume	130,856
Avg Vol	55,698
Day's Range	N/A - N/A
Shares Out	120,000.00
Stochastic %K	36%
Beta	N/A
Analysts	Strong Buy
Price Target	$15.00